Literature DB >> 20484418

Monitoring tumor response to therapy with 18F-FLT PET.

Wolfgang A Weber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20484418     DOI： 10.2967/jnumed.109.071217

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  12 in total

Review 1.  Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Authors:  Giampaolo Tomasi; Federico Turkheimer; Eric Aboagye
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

2.  An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.

Authors:  Heather Keen; Bernd Pichler; Damaris Kukuk; Olivier Duchamp; Olivier Raguin; Aoife Shannon; Nichola Whalley; Vivien Jacobs; Juliana Bales; Neill Gingles; Sally-Ann Ricketts; Stephen R Wedge
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

3.  PET imaging of early response to the tyrosine kinase inhibitor ZD4190.

Authors:  Min Yang; Haokao Gao; Yongjun Yan; Xilin Sun; Kai Chen; Qimeng Quan; Lixin Lang; Dale Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-01       Impact factor: 9.236

Review 4.  Applications of PET imaging with the proliferation marker [18F]-FLT.

Authors:  M Peck; H A Pollack; A Friesen; M Muzi; S C Shoner; E G Shankland; J R Fink; J O Armstrong; J M Link; K A Krohn
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-03-04       Impact factor: 2.346

Review 5.  Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Kendall Kiser; Lisanne van Dijk; Nadia Roxanne Livingstone; Hesham Elhalawani; Baher Elgohari; Brigid McDonald; Juan Ventura; Abdallah Sherif Radwan Mohamed; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-10-31       Impact factor: 3.722

6.  3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.

Authors:  Amarnath Challapalli; Tara Barwick; Rachel A Pearson; Shairoz Merchant; Francesco Mauri; Elizabeth C Howell; Katherine Sumpter; Ross J Maxwell; Eric O Aboagye; Rohini Sharma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-12       Impact factor: 9.236

7.  A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.

Authors:  Jae-Cheol Jo; Yong Sang Hong; Kyu-Pyo Kim; Jae-Lyun Lee; Jeeyun Lee; Young Suk Park; Sun Young Kim; Jin-Sook Ryu; Jong-Seok Lee; Tae Won Kim
Journal:  Invest New Drugs       Date:  2014-01-16       Impact factor: 3.850

8.  Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.

Authors:  Shan Tan; Hao Zhang; Yongxue Zhang; Wengen Chen; Warren D D'Souza; Wei Lu
Journal:  Med Phys       Date:  2013-10       Impact factor: 4.071

9.  Multimodality imaging of tumor response to doxil.

Authors:  Fan Zhang; Lei Zhu; Gang Liu; Naoki Hida; Guangming Lu; Henry S Eden; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011-06-06       Impact factor: 11.556

10.  [18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.

Authors:  Christopher Cawthorne; Natalie Burrows; Roben G Gieling; Christopher J Morrow; Duncan Forster; Jamil Gregory; Marc Radigois; Alison Smigova; Muhammad Babur; Kathryn Simpson; Cassandra Hodgkinson; Gavin Brown; Adam McMahon; Caroline Dive; Duncan Hiscock; Ian Wilson; Kaye J Williams
Journal:  Mol Cancer Ther       Date:  2013-02-20       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.